World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
25506
World Ranking
18326
National Ranking
606

Jean Revuz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jean Revuz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 331 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jean Revuz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jean Revuz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jean Revuz is affiliated with Université Paris Cité in France and specializes in medical research focusing primarily on dermatology and surgery. Their work contributes to understanding both Hidradenitis Suppurativa and colorectal and anal carcinomas.

Their recent publications reflect this focus, including:

  • Proposed Definitions of Typical Lesions in Hidradenitis Suppurativa, 2020, Dermatology
  • Jean-Claude Roujeau, 2021, Annales de Dermatologie et de Vénéréologie - FMC

Jean Revuz collaborates with several frequent co-authors, including Mathilde Daxhelet, Mariano Suppa, Jonathan M. L. White, Farida Benhadou, and Linnea Thorlacius.

The main fields of study in which Jean Revuz has contributed are:

  • Medicine

Within these, the subfields of dermatology and surgery are specifically represented in their research output.

Frequent publication venues where Jean Revuz's work appears include:

  • Dermatology
  • Annales de Dermatologie et de Vénéréologie - FMC

The principal topics addressed in Jean Revuz's research are:

  • Hidradenitis Suppurativa and Treatments
  • Colorectal and Anal Carcinomas

Best Publications

  • Severity Scoring of Atopic Dermatitis: The SCORAD Index

    K.U. Schallreuter;Ch. Levenig;J. Berger;J. Umbert

  • SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

    Sylvie Bastuji-Garin;Nathalie Fouchard;M Bertocchi;Jean-Claude Roujeau

  • European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

    C C Zouboulis;N Desai;L Emtestam;Robert Hunger

  • Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

    Jean E. Revuz;Florence Canoui-Poitrine;Pierre Wolkenstein;Cedric Viallette

  • Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.

    Jean Revuz;Dominique Penso;Jean-Claude Roujeau;Jean-Claude Guillaume

  • Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

    Pierre Wolkenstein;Jacques Latarjet;Jean-Claude Roujeau;Corinne Duguet

  • Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.

    Nicolas Bachot;Jean Revuz;Jean-Claude Roujeau

  • Quality of life impairment in hidradenitis suppurativa : A study of 61 cases

    Pierre Wolkenstein;Anderson Loundou;Karine Barrau;Pascal Auquier

  • What causes hidradenitis suppurativa

    H Kurzen;I Kurokawa;G B E Jemec;L Emtestam

  • Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

    C. Paul;P. Wolkenstein;H. Adle;J. Wechsler

  • Erythema Multiforme With Mucous Membrane Involvement and Stevens-Johnson Syndrome Are Clinically Different Disorders With Distinct Causes

    Haudrey Assier;Sylvie Bastuji-Garin;Jean Revuz;Jean-Claude Roujeau

  • Genetic susceptibility to toxic epidermal necrolysis.

    Jean-Claude Roujeau;Thien Nhan Huynh;Christine Bracq;Jean-Claude Guillaume

  • Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis

    P Wolkenstein;O Chosidow;M L Fléchet;O Robbiola

  • Diagnostic delay in hidradenitis suppurativa is a global problem.

    D.M. Saunte;J. Boer;A. Stratigos;J.C. Szepietowski

  • Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

    Florence Canoui-Poitrine;Florence Canoui-Poitrine;Jean E. Revuz;Pierre Wolkenstein;Cédric Viallette

  • Association between benign and malignant peripheral nerve sheath tumors in NF1.

    T. Tucker;P. Wolkenstein;J. Revuz;J. Zeller

  • Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.

    G. Gener;F. Canoui-Poitrine;J.E. Revuz;O. Faye

  • The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

    Jean-Claude Guillaume;Jean-Claude Roujeau;Jean Revuz;Dominique Penso

  • Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: A prospective study of 54 patients

    Laurence Valeyrie;Sylvie Bastuji-Garin;Jean Revuz;Nicolas Bachot

  • Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

    L. Valeyrie-Allanore;P. Wolkenstein;L. Brochard;N. Ortonne

Frequent Co-Authors

Jean-Claude Roujeau
Jean-Claude Roujeau Université Paris Cité
Pierre Wolkenstein
Pierre Wolkenstein Assistance Publique – Hôpitaux de Paris
Martine Bagot
Martine Bagot Université Paris Cité
Olivier Chosidow
Olivier Chosidow Université Paris Cité
Brigitte Dreno
Brigitte Dreno University of Nantes
Gregor B. E. Jemec
Gregor B. E. Jemec University of Copenhagen
Christos C. Zouboulis
Christos C. Zouboulis Medizinische Hochschule Brandenburg Theodor Fontane
Romain K. Gherardi
Romain K. Gherardi Paris-Est Créteil University
Jean-Hilaire Saurat
Jean-Hilaire Saurat University of Geneva
Louis Dubertret
Louis Dubertret University of Münster

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about Medicine but searching for more flexible or affordable routes within healthcare, consider pursuing related online degrees. The growth of online education now makes a wide range of medical and health programs more accessible than ever, letting students tailor their career paths and study schedules.

For those interested in records management or healthcare administration, exploring the cheapest medical billing and coding online courses is a great start. These programs train you for vital jobs in the growing field of medical billing, often at a fraction of traditional tuition costs.

Nursing continues to be in high demand across the healthcare industry. Aspiring or practicing nurses can now enroll in cheapest online msn programs to advance their credentials and specialize in areas like leadership, education, or clinical roles. Those aiming to become nurse practitioners should look into affordable online fnp programs that open doors to advanced practice and higher earning potential.

Ambitious nurses interested in research, policy, or academia can also consider an online nursing doctorate, which paves the way for leadership roles in healthcare innovation. With these online degree options, students can chart unique and rewarding career paths across the US healthcare landscape.

Best Scientists Citing Jean Revuz

Trending Scientists

Recently Published Articles